Noted a shift of large customer orders from Q4 2025 into the first half of 2026 due to customer capital and budgeting ...

NORTHAMPTON, MA / ACCESS Newswire / February 25, 2026 / This year marks a significant milestone for Inogen Alliance: 25 years as a global Alliance dedicated to advancing environmental, health, safety, ...

Delivered full year revenue growth of approximately 4%. Significantly improved profitability with 2025 net loss of $22.7 ...

Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last year, primarily driven by higher growth in international ...

Q4 2025 earnings call recap: revenue growth, 2026 guidance, Simeox & CPAP expansion, margins, and $30M buyback—read key takeaways.

For the year, the company reported a loss of $22.7 million, or 86 cents per share. Revenue was reported as $348.7 million. Inogen expects full-year revenue in the range of $366 million to $373 million ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of ...

A downtrend has been apparent in Inogen (INGN) lately with too much selling pressure. The stock has declined 10% over the ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth ...

The stock sinks after the medical device marker slashes its full-year guidance. Revenue grew 14% to $90.2 million. That beat the $89.6 million that Wall Street was expecting. Gross margin rose 150 ...

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsLorna Williams - Senior Vice President of Investor ...